AI Platform GPS Speeds Up Drug Discovery for Liver Cancer

A research team led by Michigan State University has developed a new artificial intelligence platform called GPS ^[1][2]. This system predicts how specific chemicals influence gene expression by analyzing their molecular structures ^[2][3]. Researchers successfully used the technology to identify new treatment candidates for liver cancer and pulmonary fibrosis ^[1][2]. ## Accelerating Treatment Candidates The GPS platform significantly shortens the time needed to identify effective drugs for complex diseases ^[1]. In testing, the AI predicted chemical impacts on genes without requiring initial laboratory trials for every substance ^[2]. This method helps scientists prioritize which compounds are most likely to work in clinical settings ^[3]. The study demonstrates that AI can speed up the early stages of drug development ^[1]. By focusing on gene expression changes, the system provides a detailed view of how new drugs interact with human biology ^[2][3]. The findings were part of a collaborative effort involving several institutions ^[2].